Bacterial Meningitis

• FDA approval · 2025-08-21
  FDA Approved: MEROPENEM — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application for Meropenem submitted by BluePoint Laboratories (ANDA205883), confirming approval of a supplementa…

• FDA approval · 2025-06-23
  FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)

  FDA approved the original application for a generic meropenem product manufactured by Brooks SterisScience Limited.

• FDA approval · 2024-07-22
  FDA Approved: MEROPENEM — Original Application (Qilu Antibiotics Pharmaceutical Co., Ltd.)

  FDA approved the original application for Meropenem from Qilu Antibiotics Pharmaceutical Co., Ltd., authorizing sale of a generic Meropenem …

• FDA approval · 2022-08-18
  FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)

  FDA approves Brooks SterisScience Limited's original application for generic meropenem (Meropenem) for multiple susceptible bacterial infect…

• FDA approval · 2016-06-29
  FDA Approved: CEFTRIAXONE SODIUM — Original Application (Qilu Pharmaceutical Co., Ltd.)

  FDA approved the Original Application for ceftriaxone sodium from Qilu Pharmaceutical Co., Ltd., a broad-spectrum cephalosporin used to trea…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2011-10-26
  FDA Approved: MEROPENEM — Original Application (Fresenius Kabi USA, LLC)

  FDA approves Fresenius Kabi USA, LLC's original application for Meropenem as an injectable generic antibiotic.